Mosunetuzumab
Drug timelines are a Plus or Pro feature.
29 regulatory and trial events tracked for Mosunetuzumab, covering 2024-03-25 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma [Phase 1, Phase 2]